| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Invivyd, Inc. | Director | Common Stock | 11,241,580 | $5,008,124 | $0.4455 | 22 Mar 2025 | Indirect |
| FRACTYL HEALTH, INC. | Director, 10%+ Owner | Common Stock | 1,251,900 | $1,607,064 | $1.28 | 14 Mar 2025 | Indirect |
| FRACTYL HEALTH, INC. | Director, 10%+ Owner | Common Stock | 17,901 | $22,980 | $1.28 | 14 Mar 2025 | Direct |
| FRACTYL HEALTH, INC. | Director, 10%+ Owner | Stock Option | 22,500 | 11 Jun 2025 | Direct | ||
| Invivyd, Inc. | Director | Stock Option (Right to Buy) | 8,219 | 20 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GUTS | FRACTYL HEALTH, INC. | 11 Jun 2025 | 1 | $0 | 4 | Director, 10%+ Owner | 13 Jun 2025, 16:05 |
| IVVD | Invivyd, Inc. | 20 May 2025 | 1 | $0 | 4 | Director | 22 May 2025, 16:06 |
| IVVD | Invivyd, Inc. | 24 Mar 2025 | 1 | $0 | 4 | Director | 26 Mar 2025, 17:28 |
| IVVD | Invivyd, Inc. | 22 Mar 2025 | 0 | $0 | 3 | Director | 26 Mar 2025, 17:25 |
| GUTS | FRACTYL HEALTH, INC. | 14 Mar 2025 | 1 | +$22,980 | 4 | Director, 10%+ Owner | 18 Mar 2025, 19:57 |
| GUTS | Fractyl Health, Inc. | 06 Feb 2024 | 8 | +$4,999,995 | 4 | Director, 10%+ Owner | 08 Feb 2024, 16:37 |
| GUTS | Fractyl Health, Inc. | 01 Feb 2024 | 1 | $0 | 4 | Director | 05 Feb 2024, 17:11 |
| GUTS | Fractyl Health, Inc. | 01 Feb 2024 | 0 | $0 | 3 | Director, 10%+ Owner | 01 Feb 2024, 18:25 |
| IVVD | Adagio Therapeutics, Inc. | 28 Mar 2022 | 0 | $0 | 4 | Director, Other*, 10%+ Owner | 30 Mar 2022, 21:04 |
| IVVD | Adagio Therapeutics, Inc. | 10 Aug 2021 | 5 | +$33,949,000 | 4 | Director, 10%+ Owner | 12 Aug 2021, 21:27 |
| IVVD | Adagio Therapeutics, Inc. | 05 Aug 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Aug 2021, 19:56 |
| IVVD | Adagio Therapeutics, Inc. | 05 Aug 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 05 Aug 2021, 21:26 |